| P50 | author | Kenji Tamura | Q80116025 |
| | Akihiko Shimomura | Q86352626 |
| | Takahiro Ochiya | Q89401456 |
| | Jun Sato | Q90655988 |
| | Yusuke Yamamoto | Q90655992 |
| | Juntaro Matsuzaki | Q43076693 |
| P2093 | author name string | Hiromi Sakamoto | |
| | Satoko Takizawa | |
| | Yoshitaka Narita | |
| | Makoto Ohno | |
| | Junpei Kawauchi | |
| P2860 | cites work | microRNAs as oncogenes and tumor suppressors | Q29619907 |
| | Circulating microRNAs in breast cancer and healthy subjects | Q33447949 |
| | Oncogenic microRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum | Q33824699 |
| | Heparanase-induced GEF-H1 signaling regulates the cytoskeletal dynamics of brain metastatic breast cancer cells | Q33924987 |
| | Biologic profiling of lymph node negative breast cancers by means of microRNA expression | Q34136195 |
| | Circulating miR-148b and miR-133a as biomarkers for breast cancer detection | Q34221705 |
| | Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. | Q51535040 |
| | Targeting the Metastatic Bone Microenvironment by MicroRNAs. | Q55092271 |
| | Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update | Q57130157 |
| | MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets | Q57200273 |
| | Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasis | Q81500082 |
| | Serum microRNA-155 as a potential biomarker to track disease in breast cancer | Q34447755 |
| | Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer | Q34613472 |
| | MicroRNA-1258 suppresses breast cancer brain metastasis by targeting heparanase | Q34807549 |
| | Plasma microRNA panel for minimally invasive detection of breast cancer | Q35032320 |
| | MicroRNA-484 is more highly expressed in serum of early breast cancer patients compared to healthy volunteers | Q35123674 |
| | Targeting of Runx2 by miR-135 and miR-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease | Q35251618 |
| | Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrier | Q35407588 |
| | Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease | Q35584190 |
| | miR-20b is up-regulated in brain metastases from primary breast cancers | Q35828532 |
| | miR-509 suppresses brain metastasis of breast cancer cells by modulating RhoC and TNF-α. | Q35931711 |
| | miR-218 directs a Wnt signaling circuit to promote differentiation of osteoblasts and osteomimicry of metastatic cancer cells | Q36451980 |
| | Functional single nucleotide polymorphism in IL-17A 3' untranslated region is targeted by miR-4480 in vitro and may be associated with age-related macular degeneration | Q36467703 |
| | Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer | Q36546638 |
| | miR-7 suppresses brain metastasis of breast cancer stem-like cells by modulating KLF4. | Q36620966 |
| | Novel combination of serum microRNA for detecting breast cancer in the early stage. | Q36746303 |
| | Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients | Q37394399 |
| | Unravelling site-specific breast cancer metastasis: a microRNA expression profiling study | Q37709430 |
| | MicroRNAs: miRRORS of health and disease | Q37855081 |
| | MicroRNAs in brain metastases: big things come in small packages. | Q38058743 |
| | MicroRNAs in brain metastases: potential role as diagnostics and therapeutics. | Q38219675 |
| | Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial | Q38406445 |
| | Metastatic behavior of breast cancer subtypes | Q38416421 |
| | miR-130b-3p inhibits cell invasion and migration by targeting the Notch ligand Delta-like 1 in breast carcinoma | Q38717877 |
| | Brain metastasis in breast cancer: a comprehensive literature review | Q38748013 |
| | Brain metastasization of breast cancer. | Q38877631 |
| | Accurate classification of metastatic brain tumors using a novel microRNA-based test | Q39511443 |
| | Glucocorticoid treatment for brain metastases and epidural spinal cord compression: a review | Q39634275 |
| | Identification of circulating microRNA signatures for breast cancer detection | Q43511958 |
| | Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study | Q43522608 |
| | Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer | Q46116627 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P304 | page(s) | e0221538 | |
| P577 | publication date | 2019-10-11 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Brain metastasis-related microRNAs in patients with advanced breast cancer | |
| P478 | volume | 14 | |